Alkermes Plc (ALKS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alkermes Plc   (NASDAQ: ALKS)


Alkermes Plc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alkermes Plc's ROI in the second quarter of 2026?
Alkermes Plc achieved a return on average invested assets (ROI) of 2.36 % in its second quarter of 2026, this is above ALKS's average return on investment of -2.22%.
Alkermes Plc s investments during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

Within the Healthcare sector 9 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 1276, from total ROI ranking in the first quarter of 2026 at 1289.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 71.16 % 43.62 % 12.93 % 5.97 % 1.38 %
Y / Y Net Income Change TTM -81.02 % -56.7 % -26.82 % 84.41 % 281.41 %
Investment (TTM) in Millions 3,731 3,659 1,944 1,855 1,747
Return On Investment (TTM) 2.36 % 6.64 % 13.46 % 20.05 % 21.32 %
ALKS's Overall Ranking # 1276 # 1289 # 510 # 45 # 260
Seq. Investment Change TTM 21.56 % 28.12 % 6.25 % 3.44 % 2 %
Seq. Net Income Change TTM -56.7 % -36.8 % -28.68 % -2.76 % -1.21 %
Net Income (TTM) in Millions 66 153 242 339 348

ALKS Company Profile >> Back to ALKS Roi Comparisons >> See Annual ALKS Return On Investment



Return On Investment ALKS's Ranking
Within: No.
Industry # 2
Sector # 10
Overall # 1276

Return On Investment Statistics
High Average Low
25.72 %
-2.22 %
-17.14 %
(Mar 31 2024)   (Jun 30 2016)







Financial Statements
Alkermes Plc's II. Quarter Investments $ 3,731 Millions ALKS's Balance sheet
Alkermes Plc's II. Quarter Income $ 1 Millions Quarterly ALKS's Income Statement
ALKS's Income by Division See ALKS's Income by Division


ALKS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,880 1,521 1,540 1,376 1,438
Y / Y Investment Growth 23.62 % -1.25 % 11.91 % -4.25 % 4.5 %
Net Income in Millions 242 367 356 -158 -48
Y / Y Net Income Growth -34.16 % 3.18 % - - -
Annual Return On Investment 12.85 % 24.13 % 23.1 % -11.5 % -3.35 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 12.85 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALKS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALKS's Competitors
Subscribers only: Roi for Alkermes Plc's Suppliers
Subscribers only: Return On Investment for ALKS's Customers

Other Ratios
ALKS's Roa ALKS's Inventory Turnover Ratio ALKS's Growth Rates ALKS's Dividend Statistics
ALKS's Profitability Ratios ALKS's Asset Turnover Ratio ALKS's Dividend Growth
ALKS's Roe ALKS's Valuation Ratios ALKS's Financial Strength Ratios ALKS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %

Date modified: 2026-09-26T06:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.